Technology News and Research

RSS

Pfizer, Visterra collaborate to discover novel antibodies

Visterra Inc., developer of novel therapeutics to treat major diseases, announced today that it has entered into a collaboration agreement with Pfizer to discover novel antibodies using Visterra's proprietary platform.

11 Sep 2012

FDA clears Covidien’s LigaSure technology for ENT procedures

Covidien, a leading global provider of healthcare products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LigaSure curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat (ENT) procedures.

11 Sep 2012

DATATRAK announces technology and services agreement with Bellicum

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the award of a multi-million dollar, five-year technology and services agreement with Bellicum Pharmaceuticals.

11 Sep 2012

Acacia subsidiary obtains patent for stent graft technology

Acacia Research Corp announced today that a subsidiary has acquired a patent for stent graft technology.

11 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

In Florida, Obama talks Medicare

President Barack Obama promised to fight GOP efforts to "privatize" the health insurance program for senior citizens, charging that the plan advanced by Republican nominee Mitt Romney would cost seniors more.

11 Sep 2012

New method can measure methyl mercury at unprecedentedly small concentrations

A strip of glass covered in hairy nanoparticles can cheaply and conveniently measure mercury, which attacks the nervous system, and other toxic metals in fluids.

11 Sep 2012

Methodist Hospital develops new technology to rapidly detect drug-resistant TB

Technology developed by scientists at The Methodist Hospital Research Institute could halve the time it takes to diagnose tuberculosis infection, and also tell doctors in a day or two whether the bacteria are drug resistant -- a process that currently takes weeks. Initial tests of the device were recently described in Scientific Reports, a Nature online journal.

11 Sep 2012

Mont. ballot initiative banning individual mandate could be powerful message

In the meantime, programs in Missouri and Minnesota are being held up as examples of how provisions of the health law could unfold across the nation.

11 Sep 2012

Kaleida Health's Gates Vascular Institute installs Vantage Titan 3T MR system from Toshiba

Providing patient-friendly 3T MR imaging with outstanding image quality, Kaleida Health's Gates Vascular Institute (GVI) in Buffalo, N.Y., installed the Vantage Titan 3T MR system from Toshiba America Medical Systems, Inc., the 1,400th Vantage MR installation worldwide.

11 Sep 2012

American Association of Critical-Care Nurses invites clinicians and researchers to apply for grants

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

11 Sep 2012

Bio DG’s novel metal system receives U.S. patent for use in implantable medical devices

Bio DG announced today that its patent for a novel metal system for use as biodegradable material in developing implantable medical devices was granted by the U.S. Patent Office on August 21, 2012.

11 Sep 2012

Study discovers pathways that govern instability of GAA/TTC repeats

A study of more than 6,000 genes in a common species of yeast has identified the pathways that govern the instability of GAA/TTC repeats. In humans, the expansions of these repeats is known to inactivate a gene - FXN - which leads to Friedreich's ataxia, a neurodegenerative disease that is currently incurable. In yeast, long repeats also destabilize the genome, manifested by the breakage of chromosomes.

11 Sep 2012

Annovation Biopharma to develop novel anesthetics with $8M Series A financing

Annovation Biopharma, a biotechnology company focused on creating more effective, safer therapies for anesthesia and critical care, has raised $8M in a Series A financing led by Atlas Venture, Partners Innovation Fund, and new strategic investor The Medicines Company.

10 Sep 2012

Florida Hospital Tampa adopts FDA approved Trevo Pro Clot Retriever

Florida Hospital Tampa and Dr. James E. Lefler are the first in the Tampa Bay area to adopt the new FDA approved device called the Trevo Pro Clot Retriever manufactured by Stryker. The Trevo Pro is the next generation in clot removal technology.

10 Sep 2012

Adult stem cell technology holds hope for erectile dysfunction treatment

After more than a decade of short-term cures to erectile dysfunction, most aimed at symptoms rather than the underlying issues of nerve damage, a new approach has emerged from adult stem cell technology developed by RNL Bio. Dr. Ji Youl Lee and the RNL Stem Cell Technology Institute (RNL SCTI) team, working at St. Mary's Hospital in Seoul, found in animal studies that adipose (fat) derived adult human stem cells, grown in culture, were very effective in treating cavernous nerve injury.

10 Sep 2012

Islet Sciences licenses noninvasive technology from Winthrop for detecting Beta cell death

Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Winthrop University Hospital. This technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences licensed last month.

10 Sep 2012

Argus introduces integrated care management solution

Argus Health Systems, Inc., a subsidiary of DST Inc., and a leading independent transparent pharmacy benefit administrator, announced today the availability of CareConnect to their customers. This integrated care management solution provides care teams with a comprehensive view of a member, including retrospective and prospective data to guide the best utilization of benefits and services to help drive improved outcomes.

10 Sep 2012

AB SCIEX launches Eksigent ekspert nanoLC 400 system

AB SCIEX, a global leader in life science analytical technologies, today announced the launch of the Eksigent ekspert nanoLC 400 system.

10 Sep 2012

Concussion: an interview with Dr Rob Reid

Concussion happens when something produces a concussive force to the head, such as a blow to the head. The definition from the 2008 consensus, which was in Zurich, is, “concussion is defined as a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces.”

10 Sep 2012